C反应蛋白/白蛋白比值(CAR)在急性冠脉综合征患者病情评估及预后的价值  

The Value of C-Reactive Protein/Albumin Ratio (CAR) in the Evaluation and Prognosis of Patients with Acute Coronary Syndrome

作　　者：程雅林 蔡国强 

机构地区：[1]重庆医科大学第一临床学院,重庆 [2]重庆市垫江县人民医院心血管内科,重庆

出　　处：《临床医学进展》2025年第2期120-128,共9页Advances in Clinical Medicine

摘　　要：急性冠脉综合征(ACS)是心血管疾病中常见且严重的一类疾病,其早期诊断和准确的预后评估对于改善患者结局至关重要。近年来,C反应蛋白(CRP)和白蛋白(ALB)作为炎症和营养状态的指标,逐渐受到重视,相关研究揭示了二者在炎症相关性疾病中的价值。C反应蛋白/白蛋白比值(CAR)则是基于这两者衍生出的一个综合性指标,能够更全面地反映个体的炎症状态和全身状况,且有研究证实CAR在ACS患者中有较好的病情评估和预后预测价值。本文对此主题进行综述,探讨CRP、ALB及CAR在ACS患者病情评估及预后中的价值。Acute coronary syndrome (ACS) is a common and serious type of cardiovascular disease. Its early diagnosis and accurate prognosis evaluation are crucial to improving the outcome of patients. In recent years, C-reactive protein (CRP) and albumin (ALB) have been paid more and more attention as indicators of inflammation and nutritional status. Related studies have revealed the value of both in inflammation-related diseases. C-reactive protein to albumin ratio (CAR) is a comprehensive index derived from these two, which can reflect the individual’s inflammatory state and systemic condition more comprehensively. The existing evidence shows that CAR shows certain potential value in the evaluation of ACS, including its application in the severity assessment and prognosis prediction of coronary artery disease. This article aims to briefly explore the importance of CRP, ALB and CAR in ACS, in order to provide new ideas for the development and prognosis evaluation of ACS patients.

关 键 词：C反应蛋白 白蛋白 急性冠脉综合征 预后 

分 类 号：R54[医药卫生—心血管疾病]